Why a Joint-Hypermobility Disorder Defies Simple Genetic Explanation
New insights highlight how a single gene defect can ripple across many tissues, complicating the link between cause and symptoms.
Clinical AI, drug discovery, devices, and regulatory approvals.
New insights highlight how a single gene defect can ripple across many tissues, complicating the link between cause and symptoms.
Forbes' latest ranking shows healthcare remains a major source of American wealth, with physicians among the top earners.
A new RNA-based approach could address the muscle loss associated with GLP-1 drugs, which often leads to weight regain as fat after treatment stops.
A study shows machine learning can distinguish levels of psychological resilience in healthcare workers using pandemic-era data.
New research suggests that two protective genetic pathways may work together to reduce Alzheimer's risk, helping explain why not all APOE ε4 carriers develop dementia.
New research ties poor maternal sleep in late pregnancy to lower infant weight in the first six months but higher weight by ages 1-2, especially in boys and term births.
The approval of Zanvastro marks the first treatment for a rare, progressive neurological disorder that has long had no options.
A new study using brain scans suggests long COVID's persistent fatigue and brain fog may stem from damage to dopamine-producing neurons.
First harmonized international safety recommendations define maximum scan times based on the displayed thermal index.
A research brief in Pediatrics finds over a third of pediatricians say immigrant families in their practices are skipping medical care for their children.
A researcher is using microfluidic chips to recreate the environments metastatic prostate cancer travels through, motivated by conversations with patients facing terminal prognoses.
The biotech is preparing to go public, building on recent financing and a string of large pharmaceutical partnerships.
A preclinical study reveals how estrogen receptor alpha shields the right heart in pulmonary hypertension.
A phase 2 trial shows Roche's dual GLP-1/GIP receptor agonist hit its primary endpoints, suggesting a new option for Type 2 diabetes with overweight or obesity.
Researchers at the University of Texas Medical Branch are contributing to a global push to put brain health at the center of healthcare delivery.
A care model that combines checkups with peer support may help the more than one in five U.S. adults living with chronic pain.
A new brain-mapping framework reveals how information routing between neural networks changes during pain and movie watching, highlighting the dynamic nature of brain communication.
Brian Blase of the Paragon Health Institute remains committed to deep Medicaid reductions and, according to a new report, is training his attention on the Affordable Care Act next.